Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jain

Showing results (641-650 of 658) with videos related to

Pageof 66
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Indian Journal of Endocrinology and Metabolism|May 6, 2015
Type 1 diabetes: Awareness, management and challenges: Current scenario in IndiaK M Prasanna Kumar, Banshi Saboo, P V Rao, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 30, 2023
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical studyS M Rowe, J B Zuckerman, D Dorgan, et al.
BMC Rheumatology|October 11, 2025
Global prevalence of metabolic syndrome in patients with Rheumatoid arthritis: a systematic review and meta-analysisMaryam Jafari, Kishan Patel, Abinash Mahapatro, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
The Lancet. Diabetes & Endocrinology|April 24, 2022
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional studyRanjit Mohan Anjana, Ranjit Unnikrishnan, Mohan Deepa, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Breast Cancer Research and Treatment|March 5, 2016
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III studyMinish M Jain, Smita U Gupte, Shekhar G Patil, et al.
JCO Clinical Cancer Informatics|March 1, 2024
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient DataLevente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trialN J Chao, D S Snyder, M Jain, et al.
Pageof 66

Showing results (641-650 of 658) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Indian Journal of Endocrinology and Metabolism|May 6, 2015
Type 1 diabetes: Awareness, management and challenges: Current scenario in IndiaK M Prasanna Kumar, Banshi Saboo, P V Rao, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 30, 2023
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical studyS M Rowe, J B Zuckerman, D Dorgan, et al.
BMC Rheumatology|October 11, 2025
Global prevalence of metabolic syndrome in patients with Rheumatoid arthritis: a systematic review and meta-analysisMaryam Jafari, Kishan Patel, Abinash Mahapatro, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
The Lancet. Diabetes & Endocrinology|April 24, 2022
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional studyRanjit Mohan Anjana, Ranjit Unnikrishnan, Mohan Deepa, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Breast Cancer Research and Treatment|March 5, 2016
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III studyMinish M Jain, Smita U Gupte, Shekhar G Patil, et al.
JCO Clinical Cancer Informatics|March 1, 2024
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient DataLevente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trialN J Chao, D S Snyder, M Jain, et al.
Pageof 66